OakChart

Enovis Corp

ENOVHealthcare·Medical Devices·USA·Small·NYSE·Nov 11 • 11:19 AM ET

28.34+0.12 (0.44%)
2026-11-11 17:19 CET
Market cap
1,628.15 USD m
Revenue, TTM
2,306.42 USD m
Net income, TTM
-525.75 USD m
Free cash flow, TTM
69.56 USD m
EPS diluted, TTM
-9.19
P/E
-
Compare

Price

ENOV against its 20, 50 and 200-day averages
2050200beat
20.0025.0030.002.8M5.6MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ENOVclose 28.3520-day 22.8650-day 20.20200-day 23.1828.3552w high52w low

12.5% under the 52-week high of 32.41 on 12 Nov 2025. 52-week low 16.70 on 8 Oct 2026. Last 15 sessions, 50.7% high to low

Profile

ENOV
52-week range, 74% of the way up
16.7032.41

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

IndexRUT
Employees7802
IPOMay 08, 2008
Beta1.02
ATR, 14d1.59
Rel volume0.31
Short float18.77%
Insider own2.48%
Inst own115.33%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.64B
Enterprise Value2.97B
Income-525.75M
Sales2.31B
Book/sh25.88
Cash/sh0.23
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees7802
IPOMay 08, 2008

Ratios

P/E-
Forward P/E8.18
PEG1.68
P/S0.71
P/B1.10
P/C125.41
P/FCF23.51
EV/EBITDA7.69
EV/Sales1.29
Quick Ratio1.08
Current Ratio2.15
Debt/Eq0.90
LT Debt/Eq0.86
Option/ShortYes / Yes

Earnings

EPS (ttm)-9.19
EPS next Y3.46
EPS next Q1.03
EPS this Y12.07%
EPS next Y-6.35%
EPS next 5Y4.87%
EPS past 3/5Y-321.20% -
Sales past 3/5Y12.88% -6.05%
EPS Y/Y TTM62.02%
Sales Y/Y TTM3.28%
EPS Q/Q100.54%
Sales Q/Q1.79%
EarningsNov 05 BMO
EPS/Sales Surpr.14.72% 0.29%

Ownership

Insider Own2.48%
Insider Trans2.09%
Inst Own115.33%
Inst Trans-2.02%
ROA-12.92%
ROE-30.05%
ROIC-18.94%
Gross Margin53.54%
Oper. Margin3.94%
Profit Margin-22.80%
SMA2024.01%
SMA5040.30%
SMA20022.30%
Trades-

Technical

Shs Outstand57.69M
Shs Float56.26M
Short Float18.77%
Short Ratio6.33
Short Interest10.56M
52W High32.41 -12.54%
52W Low16.70 69.73%
Volatility7.83% 5.73%
ATR (14)1.59
RSI (14)70.69
Beta1.02
Rel Volume0.31
Avg Volume1.67M
Volume163,104

Performance

Perf Week16.07%
Perf Month49.26%
Perf Quarter10.46%
Perf Half Y10.29%
Perf YTD6.40%
Perf Year-10.04%
Perf 3Y-40.78%
Perf 5Y-67.72%
Perf 10Y-54.67%
Recom1.23
Target Price37.83
Prev Close28.22
Price28.34
Change %0.44%

Analyst ratings

latest 10 of 19
DateActionAnalystRating changeTargetImplied
Jul 09, 2026InitiatedBBMO Capital MarketsOutperform$29+2.3%
Apr 17, 2026ResumedWWilliam BlairOutperform
Jan 06, 2026InitiatedBBTIG ResearchBuy$41+44.6%
Oct 03, 2024InitiatedJJMP SecuritiesMkt Outperform$62+118.7%
Jun 13, 2024InitiatedJJP MorganNeutral$53+87.0%
Feb 13, 2024InitiatedSStephensOverweight$72+154.0%
Jan 22, 2024InitiatedUUBSBuy$75+164.6%
Jan 03, 2024InitiatedWWilliam BlairOutperform
Dec 15, 2023ReiteratedNNeedhamBuy$62 → $70+147.0%
Oct 20, 2023InitiatedRROTH MKMBuy$75+164.6%

Peers

Mkt cap
TickerCompanyMkt cap
ZBHZimmer Biomet Holdings Inc20.13B
SNNSmith & Nephew plc ADR12.90B
SYKStryker Corp120.43B
SIShoulder Innovations Inc455.90M
BVSBioventus Inc937.83M
OFIXOrthofix Medical Inc292.04M
KIDSOrthoPediatrics corp882.93M
CNMDConmed Corp1.52B
ATECAlphatec Holdings Inc1.16B
SIBNSI-BONE Inc1.12B

Insider trading

latest 14 of 20
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Wienbar Sharon LDirectorNov 06 '26Buy27.5590724,98842,853Nov 10 08:00 PM
Wienbar Sharon LDirectorNov 09 '26Buy26.9892424,93043,777Nov 10 08:00 PM
Engert OliverChief Administrative OfficerSep 04 '26Buy18.802,66050,00863,898Sep 08 09:00 PM
Engert OliverChief Administrative OfficerSep 03 '26Buy19.465,140100,02461,238Sep 04 09:00 PM
Engert OliverChief Administrative OfficerSep 02 '26Buy20.322,45849,94756,098Sep 04 09:00 PM
McDonald DamienChief Executive OfficerSep 04 '26Buy19.1513,035249,620247,077Sep 04 09:00 PM
Engert OliverChief Administrative OfficerJun 15 '26Buy20.921,00020,92053,640Jun 16 09:05 PM
Engert OliverChief Administrative OfficerJun 11 '26Buy21.621,20025,94851,840Jun 15 09:00 PM
Engert OliverChief Administrative OfficerJun 10 '26Buy23.001,00023,00050,640Jun 11 09:00 PM
Engert OliverChief Administrative OfficerJun 01 '26Buy22.221,00022,22049,640Jun 03 09:00 PM
Engert OliverChief Administrative OfficerMar 13 '26Buy23.741,00023,74048,640Mar 16 09:00 PM
Engert OliverChief Administrative OfficerMar 10 '26Buy23.931,00023,93047,640Mar 12 07:35 PM
Engert OliverChief Administrative OfficerMar 09 '26Buy23.391,00023,39046,640Mar 10 09:00 PM
Engert OliverChief Administrative OfficerMar 06 '26Buy24.4175018,31045,640Mar 10 09:00 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B

News

latest 14 of 206
  • Enovis Beats And Raises Profit Guidance, But Slowing U.S. Hips And Knees And A Trimmed Revenue Ceiling Limit The Upside (Earnings Whispers) +17.20%
  • Enovis: Q3 Earnings Snapshot (Associated Press)
  • ENOVIS Announces Third Quarter 2026 Results (GlobeNewswire)
  • Enovis Faces A Flagged Soft Third Quarter As Inflation Costs Test Its Margin Story (Earnings Whispers)
  • Enovis to Host Third Quarter 2026 Results Conference Call on November 5th (GlobeNewswire)
  • Loading…
  • Enovis becomes first multi-registry industry sponsor of AAOS Registry Program (PR Newswire)
  • Enovis inks eCential takeover to develop surgical ortho robots (MedTech Dive)
  • eCential Robotics Announces Binding Offer from Enovis (PR Newswire) -16.51%
  • Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics (GlobeNewswire)
  • Enovis to Participate in the 2026 Wells Fargo Healthcare Conference (GlobeNewswire)
  • Enovis Corp (ENOV) (Q2 2026) Earnings Call Highlights: Strong Innovation Drives 5% Organic ... (GuruFocus.com) -12.82%
  • Enovis: Q2 Earnings Snapshot (Associated Press)
  • Enovis Announces Second Quarter 2026 Results (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.8800.7670.060558.73557.1213
2026Q22026-08-060.9000.847-0.021582.78581.8413
2026Q12026-05-070.8900.813-0.153589.15572.0212
2025Q42026-02-260.9500.841-9.074575.76582.8812
2025Q32025-11-060.7500.649-9.991548.9538.6110
2025Q22025-08-070.7900.719-0.643564.55554.1311
2025Q12025-05-080.8100.743-0.986558.83558.8511
2024Q42025-02-260.9800.916-12.588560.98555.0911
2024Q32024-11-060.7300.616-0.566505.22504.4411
2024Q22024-08-070.6200.593-0.340525.2525.9911
2024Q12024-05-020.5000.484-1.317516.27505.6210
2023Q42024-02-220.7900.7400.054455.02445.2410
2023Q32023-11-070.5600.539-0.337417.52414.867
2023Q22023-08-030.6100.526-0.183428.5420.067
2023Q12023-05-040.4400.377-0.430406.15389.926
2022Q42023-02-230.7200.677-0.712408.71415.766

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY3.9733.8863.4823,6673,664
2019FY3.4573.411-11.8953,3273,365
2020FY2.4082.3761.1113,0713,071
2021FY3.6813.6441.2233,8543,827
2022FY2.2702.231-0.2771,5631,570
2023FY2.4002.350-0.8951,7071,698
2024FY2.8402.780-14.9332,1082,101
2025FY3.3003.198-20.7202,2482,255
2026FY-3.698--2,336
2027FY-3.463--2,448
2028FY-3.806--2,564
2029FY-4.570--2,748

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-091305605.82601.9613.3
2026Q4S2026-11-051304606.53601.9615.79
2026Q4S2026-10-201300609.75601.86615.79
2026Q4S2026-10-101301609.75601.86615.79
2026Q4S2026-10-091311609.75601.86615.79
2026Q4S2026-10-011311609.75601.86615.79
2026Q4S2026-09-011311610.1601.86615.79
2026Q4S2026-08-311311610.09601.86615.79
2026Q4S2026-08-211311610.1601.86615.79
2026Q4S2026-08-201311610.09601.86615.79
2026Q4S2026-08-191311610.17601.86615.79
2026Q4S2026-08-141311610.17601.86615.79
2026Q4S2026-08-131301609.79601.86615.79
2026Q4S2026-08-061301609.84601.86614

Estimate history

EPS, annual-3.8293.482-11.8951.1111.223-0.277-0.895-14.933-20.721-9.1935
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.566-12.588-0.986-0.643-9.991-9.074-0.153-0.0210.054
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual3300.1842193.0833327.4583070.7691426.1881563.1011707.1972107.6232248.0492306.42
Period201720182019202020212022202320242025TTM
Sales, quarterly505.222560.975558.834564.545548.912575.758589.151582.782558.725
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual41.08239.09239.35339.49952.08354.22954.59755.87757.19557.694
Period201720182019202020212022202320242025MRQ
Shares, quarterly55.86655.87757.11957.15957.1957.19557.55357.66557.694
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,306.422,248.052,107.621,707.201,563.101,426.193,070.773,327.462,193.08
Cost of Goods Sold Incl. D&A1,071.571,081.991,081.17854.02825.72768.311,934.491,926.401,463.71
Gross Profit1,234.851,166.061,026.46853.18737.38657.881,136.281,401.06729.38
Selling, General and Administrative Excl. Other1,144.091,117.231,030.18857.95764.13681.03901.321,075.91548.76
Research and Development125.86120.3391.3075.3360.8349.0968.6061.8034.20
Other Operating Expense0.0045.820.000.000.000.000.000.000.00
Operating Income90.763.01-3.73-4.77-26.75-23.16234.96325.14180.61
Interest Expense74.1483.7257.7019.9524.9529.81107.46122.7051.58
Unusual Expense565.621,127.03768.4965.57-39.0267.4172.67154.1139.17
Net Income Before Taxes-501.90-1,159.42-822.92-67.13-2.07-121.7858.0350.4992.36
Income Taxes25.1222.294.49-13.2936.12-19.53-6.0531.63-29.51
Consolidated Net Income-527.03-1,181.71-827.42-53.84-38.19-102.2564.0818.86121.87
Net Income From Continuing Operations-527.91-1,182.53-828.10-54.37-39.72-106.8760.948.36107.59
Net Income-525.75-1,182.53-825.49-48.78-14.9962.5651.43-541.88140.20
EPS (Recurring)-2.22-6.90-5.20-0.05-0.782.152.21-9.534.16
EPS (Basic, Before Extraordinaries)-9.19-20.72-14.93-0.90-0.281.221.13-11.663.50
EPS (Diluted)-9.19-20.72-14.93-0.90-0.281.221.11-11.893.48
EBITDA385.68297.41281.17212.33176.15163.84481.19561.17322.49
Non-Operating Income (Expense)47.0948.327.0023.1610.61-1.403.212.162.50
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense26.4626.0128.2431.2537.7232.6927.1120.6821.68
Price To Earnings Ratio----127.70119.92153.70-23.24
Price To Sales Ratio0.450.681.151.791.854.951.731.491.15
Gross Margin53.5451.8748.7049.9847.1746.1337.0042.1133.26
Operating Margin3.940.13-0.18-0.28-1.71-1.627.659.778.24
Net Margin-22.80-52.60-39.17-2.86-0.964.391.67-16.296.39
Shares Outstanding57.6957.1955.8854.6054.2352.0839.5039.3539.09
Market Capitalization1,628.151,628.152,451.823,058.362,898.099,577.046,041.755,726.653,268.07

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue558.73582.78589.15575.76548.91564.54558.83560.98
Cost of Goods Sold Incl. D&A262.13265.09265.57278.77262.19272.61268.37279.14
Gross Profit296.59317.69323.58296.98286.72291.94290.46281.84
Selling, General and Administrative Excl. Other275.04294.01303.31271.73277.69284.32285.49268.32
Research and Development31.2731.6931.5331.3629.7430.7028.5323.95
Other Operating Expense0.000.000.000.000.0010.0435.780.00
Operating Income21.5523.6820.2725.269.04-2.42-30.8113.52
Interest Expense16.3218.5419.1720.1120.8321.2921.399.07
Unusual Expense18.186.2713.74527.43569.3316.1717.75678.27
Net Income Before Taxes-0.467.460.63-509.55-566.87-25.65-57.35-673.73
Income Taxes-1.688.509.049.264.0010.80-1.7729.90
Consolidated Net Income1.22-1.04-8.41-518.80-570.87-36.45-55.58-703.63
Net Income From Continuing Operations0.94-1.19-8.72-518.94-571.11-36.65-55.84-703.76
Net Income3.14-1.19-8.76-518.94-571.15-36.74-55.97-703.34
EPS (Recurring)0.270.060.01-2.62-3.02-0.44-0.77-4.09
EPS (Basic, Before Extraordinaries)0.05-0.02-0.15-9.07-9.99-0.64-0.99-12.59
EPS (Diluted)0.05-0.02-0.15-9.07-9.99-0.64-0.99-12.59
EBITDA95.0694.7193.62102.2983.4269.1340.6388.03
Non-Operating Income (Expense)12.488.5913.2712.7414.2514.2312.600.09
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.967.036.916.567.086.855.857.80
Price To Sales Ratio0.450.560.570.680.820.880.861.16
Gross Margin53.0854.5154.9251.5852.2351.7151.9850.24
Operating Margin3.864.063.444.391.65-0.43-5.512.41
Net Margin0.56-0.20-1.49-90.13-104.05-6.51-10.01-125.38
Shares Outstanding57.6957.6757.5557.1957.1957.1657.1255.88
Market Capitalization1,628.151,191.551,302.331,523.531,734.231,791.382,176.572,451.82

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments36.3948.1736.1924.30680.25101.07109.6377.15411.63
Short Term Receivables442.79407.03291.48267.38254.96517.01561.87386.59970.20
Inventories584.38547.12468.83426.64356.23564.82571.56359.65429.63
Other Current Assets143.50144.13100.0176.701,011.84178.93161.191,135.05258.38
Total Current Assets1,207.061,146.45896.52795.022,303.281,361.831,404.241,958.442,069.83
Net Property, Plant & Equipment579.32473.42334.30303.62311.60660.90664.56327.15552.80
Total Investments and Advances21.400.000.000.000.000.000.000.000.00
Long-Term Note Receivable----15.4231.8241.6362.5273.49
Intangible Assets1,955.013,010.143,188.263,094.323,088.294,977.994,921.542,126.133,555.75
Deferred Tax Assets26.90--------
Other Assets45.0588.7890.2580.292,812.75319.02354.862,141.71457.83
Total Assets3,834.744,718.784,509.334,273.258,515.917,351.557,386.836,615.966,709.70
Short Term Debt Incl. Current Port. of LT Debt59.7442.3721.57243.5629.6466.7767.665.025.77
Accounts Payable187.53179.10132.47135.63155.21330.25359.78291.23587.13
Income Tax Payable27.1821.3414.3813.6812.9757.2955.2655.5553.94
Other Current Liabilities324.02286.19201.18172.34825.77357.35374.61847.54450.55
Total Current Liabilities598.47529.00369.61565.201,023.58811.66857.311,199.351,097.38
Long Term Debt1,319.791,361.93514.8591.262,135.172,343.402,420.581,192.411,055.31
Provision for Risks Charges0.000.000.000.000.000.200.100.001.75
Deferred Tax Liabilities102.70--------
Other Liabilities321.87263.52204.18166.99695.72608.42619.21747.26828.00
Total Liabilities2,342.842,154.451,088.63823.453,854.483,763.683,897.203,139.012,982.43
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,489.642,562.263,418.393,448.094,617.383,543.393,441.433,269.763,500.41
Total Shareholders Equity1,489.642,562.263,418.393,448.094,617.383,543.393,441.433,269.763,500.41
Accumulated Minority Interest2.262.072.311.7244.0544.4948.20207.19226.85
Total Equity1,491.902,564.333,420.703,449.804,661.433,587.873,489.633,476.953,727.26
Total Liabilities & Stockholders Equity3,834.744,718.784,509.334,273.258,515.917,351.557,386.836,615.966,709.70
Book Value Per Share26.0545.8662.6163.5888.6589.7187.4583.6485.21
Tangible Book Value Per Share-8.14-8.024.226.5229.36-36.32-37.6129.25-1.35
Full-Time Employees7,8027,3676,5506,80016,20015,40015,00015,50014,300
Price to Book Ratio1.090.740.890.852.071.711.661.001.97
Return on Assets-27.65-17.95-1.24-0.62-1.350.830.121.61-1.12
Return on Equity-58.37-27.69-1.58-0.98-2.621.740.253.18-2.28
Return on Invested Capital-42.09-21.04-1.24-0.420.930.87-9.243.14-3.45
Quick Ratio1.041.131.160.651.900.980.971.331.49
Current Ratio2.022.172.431.412.251.681.641.631.89

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-526.52-1,183.62-824.82-32.73-11.7676.2845.77-517.15154.47
Depreciation294.90294.38284.80217.10202.90187.00246.23236.03141.88
Other Funds (Non Cash)544.371,093.30677.475.30-31.04132.1134.16544.1229.92
Funds from Operations268.84201.83127.43162.26166.43373.20296.94262.40259.70
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-9.8215.46-13.93-27.27-222.29-17.104.99-131.46-33.33
Cash from Operating Activities259.02217.29113.50134.99-55.86356.10301.94130.95226.37
Capital Expenditures-189.46-197.38-180.71-122.22-105.45-104.24-114.78-125.40-69.65
Net Assets From Acquisitions-4.12-26.86-769.91-152.81-73.68-223.27-69.85-3,244.56-290.92
Sale of Fixed Assets and Businesses-43.260.0032.572.757.039.551,643.7053.23
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00139.48
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00139.48
Other Uses-3.280.00-4.840.000.000.000.000.000.00
Other Sources0.001.600.000.000.000.000.000.000.00
Cash from Investing Activities-153.60-179.37-955.47-242.47-176.39-320.48-175.08-1,726.26-167.85
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock1.351.32-2.901.785.81745.183.50389.69-195.30
Repurchase of Common Pref Stock0.000.00-4.770.000.000.000.000.00-200.00
Sale of Common Pref Stock1.351.321.871.785.81745.183.50389.694.70
Proceedsfrom Stock Options1.351.321.871.785.81745.183.50389.694.70
Issuance or Reduction of Debt, Net-112.03-43.60858.52191.52-1,606.80-150.41-122.881,085.40158.24
Change in Long Term Debt-112.03-43.60858.52191.52-1,606.80-150.41-122.881,085.40158.24
Issuance of Long Term Debt532.33537.331,391.30889.32499.36967.12856.124,746.701,271.05
Reduction of Long Term Debt-644.35-580.92-532.77-697.80-2,106.16-1,117.53-979.00-3,661.30-1,112.81
Net Financing Active Other Cash Flow-15.29-10.12-8.80-65.501,135.86-9.87-12.28-12.10-10.09
Other Financing Activities Uses-15.29-10.12-8.80-65.50-7.51-9.87-12.28-12.10-10.09
Cash from Financing Activities-125.96-52.40846.82127.80-465.13584.91-131.651,463.00-47.15
Exchange Rate Effect-0.042.70-1.520.222.30-2.23-3.77-3.07-28.36
Net Change in Cash-20.58-11.783.3320.54-695.08618.30-8.56-135.39-17.00
Free Cash Flow69.5619.92-67.2112.77-161.31251.86187.155.55156.72
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow14.9476.33-239.15-28.0028.38896.4916.11
Deferred Taxes & Investment Tax Credit--2.23-10.02-27.416.32-22.19-29.22-0.59-66.57

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments13.0412.5633.1336.3933.6244.07
Short Term Receivables428.29441.85444.21442.79431.77453.70
Inventories620.15601.66602.54584.38613.75628.22
Other Current Assets186.09158.62159.80143.50200.99154.36
Total Current Assets1,247.581,214.691,239.681,207.061,280.121,280.35
Net Property, Plant & Equipment601.03602.37594.22579.32559.34525.31
Total Investments and Advances0.000.000.0021.400.000.00
Intangible Assets1,796.031,860.171,904.391,955.012,499.353,123.32
Deferred Tax Assets---26.90--
Other Assets90.9188.8993.9645.0594.5692.41
Total Assets3,735.543,766.133,832.263,834.744,433.375,021.40
Short Term Debt Incl. Current Port. of LT Debt59.2862.7760.2359.7444.0343.08
Accounts Payable200.45194.47213.62187.53198.78212.02
Income Tax Payable62.0371.0660.3427.1819.1619.82
Other Current Liabilities258.07283.75274.48324.02313.48293.27
Total Current Liabilities579.84612.05608.66598.47575.44568.18
Long Term Debt1,283.251,306.281,350.291,319.791,397.231,421.69
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---102.70--
Other Liabilities376.88368.63393.81321.87437.01450.56
Total Liabilities2,239.962,286.962,352.762,342.842,409.692,440.44
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,493.241,477.071,476.921,489.642,020.682,578.19
Total Shareholders Equity1,493.241,477.071,476.921,489.642,020.682,578.19
Accumulated Minority Interest2.342.102.572.263.002.77
Total Equity1,495.581,479.161,479.491,491.902,023.682,580.96
Total Liabilities & Stockholders Equity3,735.543,766.133,832.263,834.744,433.375,021.40
Book Value Per Share25.8825.6125.6626.0535.3345.11
Tangible Book Value Per Share-5.25-6.64-7.43-8.14-8.37-9.54
Full-Time Employees---7,802--
Price to Book Ratio1.090.810.870.750.670.68
Return on Assets-12.92-25.03-26.08-27.65-27.39-15.87
Return on Equity-30.05-54.25-55.46-58.37-51.11-28.31
Return on Invested Capital0.11-0.04-0.31-18.47-16.71-0.92
Quick Ratio1.081.001.051.041.161.15
Current Ratio2.151.982.042.022.222.25

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income3.42-1.04-8.45-520.45-570.91-36.55
Depreciation73.5071.0373.3677.0174.3871.55
Other Funds (Non Cash)10.3711.5310.46512.01559.3711.90
Funds from Operations87.2577.0337.6666.9165.9545.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-15.75-2.00-13.7121.6416.632.77
Cash from Operating Activities71.4975.0323.9588.5482.5847.77
Capital Expenditures-36.51-43.90-52.80-56.25-53.49-44.37
Net Assets From Acquisitions-2.71-1.12-0.290.00-2.57-5.43
Sale of Fixed Assets and Businesses0.000.000.00---
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses-3.280.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-42.50-45.01-53.09-12.99-56.06-49.80
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.350.380.630.000.190.79
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.350.380.630.000.190.79
Proceedsfrom Stock Options0.350.380.630.000.190.79
Issuance or Reduction of Debt, Net-28.28-42.7427.73-68.74-36.875.44
Change in Long Term Debt-28.28-42.7427.73-68.74-36.875.44
Issuance of Long Term Debt67.6132.3972.00360.3350.0055.00
Reduction of Long Term Debt-95.89-75.13-44.27-429.06-86.87-49.56
Net Financing Active Other Cash Flow-0.57-8.20-2.34-4.18-0.230.00
Other Financing Activities Uses-0.57-8.20-2.34-4.18-0.230.00
Cash from Financing Activities-28.50-50.5626.02-72.92-36.916.23
Exchange Rate Effect-0.01-0.02-0.140.13-0.071.42
Net Change in Cash0.47-20.57-3.262.77-10.465.61
Free Cash Flow34.9931.14-28.8532.2929.093.40
Price to Free Cash Flow14.9420.3636.1276.5080.41-

Revenue breakdown

Prevention and Recovery2024: 1.10B 2025: 1.14B
Reconstructive2024: 1.01B 2025: 1.11B
Foreign2024: 861.95M
United States2024: 1.25B 2025: 2.25B
Prevention and Recovery2024: 1.10B 2025: 1.14B
Reconstructive2024: 1.01B 2025: 1.11B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3018.77%10.6M56.3M1.56M
2026-10-1520.81%11.7M56.2M1.47M
2026-09-3018.78%10.6M56.2M1.46M
2026-09-1516.86%9.5M56.2M1.38M
2026-08-3116.17%9.1M56.2M1.12M
2026-08-1415.49%8.7M56.3M1.20M
2026-07-3115.18%8.5M56.3M1.16M
2026-07-1514.85%8.3M56.2M1.18M
2026-06-3016.91%9.5M56.2M1.07M
2026-06-1516.11%9.0M56.2M984.66K
2026-05-2915.41%8.7M56.2M982.70K
2026-05-1514.96%8.4M56.2M1.02M
2026-04-3016.33%9.2M56.5M985.86K
2026-04-1515.31%8.6M56.1M995.81K
2026-03-3114.55%8.1M56.0M1.08M
2026-03-1314.20%8.0M56.0M1.08M
2026-02-2714.35%8.0M56.0M1.05M
2026-02-1315.49%8.7M56.0M965.41K
2026-01-3015.56%8.7M56.0M964.17K
2026-01-1514.53%8.1M56.0M885.66K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5024.3028.000.0026.1820.000.000.997-0.0190.000
call5.0021.8025.500.0013.7430.000.000.995-0.0200.001
call7.5019.3023.000.0010.1720.000.000.993-0.0200.001
call10.0016.8020.500.008.0650.000.000.991-0.0200.001
call12.5014.3017.100.005.3190.000.000.989-0.0200.001
call15.0011.8014.704.464.4722390.000.986-0.0200.002
call17.509.3012.206.483.6403970.000.982-0.0190.002
call20.006.809.807.402.9762080.000.861-0.1380.010
call22.505.407.306.302.2561,7113.000.823-0.1250.012
call25.003.304.303.741.3391,44316.000.703-0.1940.015
call30.000.800.900.800.8481,3981,5040.400-0.0980.017
call35.000.000.250.251.0470.0051.000.117-0.0510.009
put2.500.000.050.006.9470.000.00-0.003-0.0170.000
put5.000.002.150.005.1270.000.00-0.005-0.0190.001
put7.500.002.150.053.94319.000.00-0.007-0.0190.001
put10.000.002.150.003.1250.000.00-0.009-0.0190.001
put12.500.002.150.002.4990.000.00-0.011-0.0180.001
put15.000.001.000.151.98865.000.00-0.014-0.0180.002
put17.500.000.050.011.7491260.00-0.030-0.0290.003
put20.000.002.150.052.5121010.00-0.138-0.1360.010
put22.500.000.950.251.9201500.00-0.177-0.1230.012
put25.000.002.300.002.2500.000.00-0.297-0.1910.015
put30.001.103.700.001.5230.000.00-0.616-0.0900.017
put35.005.908.100.002.0520.000.00-0.882-0.0470.009

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-10-02SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-018-KCurrent report2026-08-31SEC
2026-08-14SCHEDULE 13GSEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-07-03SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-28SCHEDULE 13G/ASEC
2026-07-08SCHEDULE 13G/ASEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-2611-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-164/A2026-06-11SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-11SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-05-28SDSpecialized Disclosure ReportSEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1149.92K200
2026-100000
2026-09449.60K400
2026-080000
2026-070000
2026-0692.09K400
2026-050000
2026-040000
2026-03120.42K600
2026-0225.50K100
2026-010000
2025-120045.30K2
2025-1174.83K100

Institutional holders

Manager% owned
BlackRock, Inc.17.89%
AMERICAN CENTURY COMPANIES INC10.61%
ABSOLUTE INVESTMENT ADVISERS, LLC8.67%
VANGUARD PORTFOLIO MANAGEMENT LLC6.82%
Rubric Capital Management LP6.78%
VANGUARD CAPITAL MANAGEMENT LLC4.32%
STATE STREET CORP4.28%
DIMENSIONAL FUND ADVISORS LP4.05%
Hood River Capital Management LLC3.99%
PRIVATE MANAGEMENT GROUP INC3.11%

Funds

Fund% owned
iShares Convertible Bond ETF16.02%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF11.18%
American Beacon SSI Alternative Income Fund10.43%
iShares Core S&P Small-Cap ETF6.03%
Global Opportunities Portfolio5.39%
Fidelity Convertible Securities Fund4.92%
Small Cap Value Fund4.55%
Fidelity Small Cap Value Fund4.04%
Avantis U.S. Small Cap Value ETF3.19%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.99%

OakChart. ENOV. Cached 15 minutes.